期刊文献+

3-硝基丙酸诱导继发性肌张力障碍大鼠模型的行为学研究 被引量:1

Behavioral research of rat models with 3-nitropropionic acid induced secondary dystonia
原文传递
导出
摘要 目的 观察3-硝基丙酸(3-NP)诱导的继发性肌张力障碍大鼠模型的行为学变化,以建立一个可靠的继发性肌张力障碍动物模型.方法 36只雄性SD大鼠按随机数字表法分为3组,每组各12只,前2组为实验组(低剂量组立体定向注射2000 nmol 3-NP至大鼠左侧尾壳核,高剂量组立体定向注射4000nmol 3-NP),第3组为对照组(注射等体积生理盐水).术后观察大鼠头部扭转和自主行为变化,平板实验观察大鼠通过时间及步幅.结果 实验组大鼠给药后开始出现姿势障碍,头部向同侧扭转,其中高剂量组扭转评分明显大于低剂量组,比较差异有统计学意义(P<0.05).平板实验结果显示:实验组大鼠通过时间较对照组明显延长,步幅较对照组明显变小,比较差异有统计学意义(P<0.05),且偏于木板一侧行走,症状随剂量增加而加重.对照组大鼠术后第2天基本恢复术前状态,无头部偏转,均顺利通过木板实验.结论 大鼠尾壳核注射3-NP可诱导产生稳定的继发性肌张力障碍动物模型. Objective To observe the behavioral changes of rats with 3-nitropropionic acid (3-NP) induced secondary dystonia to set up a kind of reliable secondary dystonia models. Methods Thirty-six SD rats were equally divided into control group and low-dosage 3-NP treatment group (2000nmol) and high-dosage 3-NP treatment group (4000 nmol). The 3-NP was injected into the left caudate putamen (CPU) in rats of the later 2 groups and sodium chloride solution was injected into the left CPU in rats of control group. Narrow board training was proceeded and camera was employed to record the dystonic posture and both the time and steps passing the board. Results As compared with the control group, 3-NP treatment groups had obvious ipsilateral dystonic posturing (P〈0.05), and the scores of dystonic posturing in the high-dosage 3-NP treatment group were significantly higher than those of that in the low-dosage 3-NP treatment group (P〈0.05). Narrow board experimental results indicated that the time was significantly extended and length of step was significantly shortened in rats of 3-NP treatment groups as compared with those in the control group (P〈0.05); rats in the treatment groups walked towards the lateral side of the boared, these symptoms became much severe following the increase of 3-NP dosage.While rats in the control group had no dystonic posture, and they can go though the board without retention. Conclusion The 3-NP injecting into the CPU of rats can induce a kind of stable animal models with secondary dystonia.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2010年第12期1208-1211,共4页 Chinese Journal of Neuromedicine
基金 北京市科技新星基金(2008-B-43)
关键词 3-硝基丙酸 肌张力障碍 动物模型 3-nitropropionic acid Dystonia Animals model
  • 相关文献

参考文献19

  • 1Ludolph AC,He F,Spencer PS,et al.3-Nitropropionic acidexogenous animal neurotoxin and possible human striatal toxin[J].Can J Neurol Sci,1991,18(4):492-498.
  • 2Ouary S,Bizat N,Altairac S,et al.Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats:implications for neuroprotection studies[J].Neuroscience,2000,97(3):521-530.
  • 3Miwa H,Nishi K,Fuwa T,et al.Effects of blockade of metabotropic glutamate receptors in the subthalamic nucleus on haloperidol-induced Parkinsonism in rats[J].Neurosci Lett,2000,282(1-2):21-24.
  • 4马羽,张凯,葛明,孟凡刚,胡文瀚,张建国.脑深部电刺激术治疗原发性全身性肌张力障碍(附2例报告)[J].中国神经精神疾病杂志,2009,35(4):212-215. 被引量:7
  • 5Bressman S.Genetics of dystonia[J].J Neural Transm Suppl,2006,(70):489-495.
  • 6Naudon L,Delf s JM,Clavel N,et al.Differential expression of glutamate decarboxylase messenger RNA in cerebellar Purkinje cells and deep cerebellar nuclei of the genetically dystonic rat[J].Neuroscience,1998,82(4):1087-1094.
  • 7Hamann M,Richter A.Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia[J].Neurobiol Dis,2004,16(1):78-84.
  • 8Klier EM,Wang H,Constantin AG,et al.Midbrain control of threedimensional head orientation[J].Science,2002,295 (5558):1314-1316.
  • 9Jinnah HA,Hess EJ,Leroux MS,et al.Rodent models for dystonia research:characteristics,evaluation,and utility[J].Mov Disord,2005,20(3):283-292.
  • 10Macia F,Escola L,Guehl D,et al.Neuronal activity in the monkey motor thalamus during bicuculline-ioduced dystonia[J].Eur J Neurosci,2002,15(8):1353-1362.

二级参考文献16

  • 1ZHANG Jian-guo ZHANG Kai WANG Zhong-cheng.Deep brain stimulation in the treatment of tardive dystonia[J].Chinese Medical Journal,2006(9):789-792. 被引量:9
  • 2ZHANG Jian-guo,ZHANG Kai,WANG Zhong-cheng,GE Ming and MA Yu Department of Neurosurgery,Beijing Tiantan Hospital,Capital University of Medical Sciences,Functional Neurosurgical Department,Beijing Neurosurgical Institute,Beijing 100050,China.Deep brain stimulation in the treatment of secondary dystonia[J].Chinese Medical Journal,2006(24):2069-2074. 被引量:9
  • 3张劲松,宦怡,孙立军,张光运,李斌,刘燕丽,郑敏文,杜渭清.山豆根中毒的脑MRI表现[J].中华放射学杂志,2007,41(2):140-142. 被引量:23
  • 4汤晓芙 黄光 等.山豆根中毒引起全身性扭转痉挛1例[J].中华医学杂志,1999,79(12):896-896.
  • 5江苏新医学院主编.中医大辞典[M].上海:上海科学技术出版社,1998:181-182;494-495.
  • 6Fornaguera J,Schwarting RK.Early behavioral changes after nigro-striatal system damage can serve as predictors of striatal dopamine depletion[J].Prog Neuropsychopharmacol Biol Psychiatry,1999,23(8):1353-1368.
  • 7Reglodi D,Lubics A,Tamás A,et al.Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease[J].Behav Brain Res,2004,151(1-2):303-312.
  • 8Hamann M,Richter A.Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia[J].Neurobiol Dis,2004,16(1):78-84.
  • 9Bhatia KP.Familial (idiopathic) paroxysmal dyskinesias:an update[J].Semin Neurol,2001,21(1):69-74.
  • 10Lorden JF,McKeon TW,Baker HJ,et al.Characterization of the rat mutant dystonic (dt):a new animal model ofdystonia musculorum deformans[J].J Neurosci,1984,4(8):1925-1932.

共引文献9

同被引文献8

  • 1Gopinath K, Prakash D, Sudhandimn G. Neuroprotect:ive effect of naringin, a dietary flavonoid against 3-nitropro- pionic acid-induced neuronal apoptosis [J]. Neurochem Int, 2011, 59(7): 1066-1073.
  • 2Liot G, Bossy B, Lubitz S, et al. Complex Ⅱ inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway [J]. Cell Death Differ, 2009, 16(6): 899-909.
  • 3Marti M, Mela F, Ulazzi L, et al. Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease [J]. Eur J Neurosci, 2003, 18(4): 759-767.
  • 4Storgaard J, Kornblit BT, Zimmer J, et ol. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate [J]. Exp Neurol, 2000, 164(1): 227-235.
  • 5Kumar P, Kalonia H, Kumar A. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity [J]. Eur J Pharmacol, 2012, 674(2-3): 265-274.
  • 6Horie C, Suzuki Y, K_iyosawa M, et al. Decreased dopamin D2 receptor binding in the essential blepharospasm [J]. Acta Neurol Scand, 2009, 119(1): 49-54.
  • 7Ridding MC, Sheean G, Rothwell JC, et al. Changes in balance between motor cortical excitation and inhibition in focal task specific dystonia [J]. J Neurol Neurosurg Psychiatry, 1995, 59(5): 493-498.
  • 8Cuny E, Ghorayeb I, Guehl D, et ol. Sensory motor mismatch within the supplementary motor area in the dystonic monkey [J]. Neurobiol Dis, 2008, 30(2): 151-161.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部